These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27598330)

  • 1. Current Practices in Ocular Toxoplasmosis: A Survey of Brazilian Uveitis Specialists.
    Morais FB; Arantes TEFE; Muccioli C
    Ocul Immunol Inflamm; 2018; 26(2):317-323. PubMed ID: 27598330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on current practices in the management of ocular toxoplasmosis.
    Holland GN; Lewis KG
    Am J Ophthalmol; 2002 Jul; 134(1):102-14. PubMed ID: 12095816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
    Zhang Y; Lin X; Lu F
    Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of ocular toxoplasmosis : a survey of German-speaking ophthalmologists].
    Torun N; Sherif Z; Garweg J; Pleyer U
    Ophthalmologe; 2008 Nov; 105(11):1023-8. PubMed ID: 18369638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current practices in the management of ocular toxoplasmosis.
    Engstrom RE; Holland GN; Nussenblatt RB; Jabs DA
    Am J Ophthalmol; 1991 May; 111(5):601-10. PubMed ID: 2021170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis.
    Souza CE; Nascimento H; Lima A; Muccioli C; Belfort R
    Ocul Immunol Inflamm; 2018; 26(7):1041-1044. PubMed ID: 28448726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis.
    Opremcak EM; Scales DK; Sharpe MR
    Ophthalmology; 1992 Jun; 99(6):920-5. PubMed ID: 1630782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fuchs' heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?
    Jad A; Céline T; Bahram B; Phuc L; Nathalie C
    Int Ophthalmol; 2013 Apr; 33(2):189-94. PubMed ID: 23070707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for ocular toxoplasmosis.
    Rothova A; Meenken C; Buitenhuis HJ; Brinkman CJ; Baarsma GS; Boen-Tan TN; de Jong PT; Klaassen-Broekema N; Schweitzer CM; Timmerman Z
    Am J Ophthalmol; 1993 Apr; 115(4):517-23. PubMed ID: 8470726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management.
    Holland GN
    Am J Ophthalmol; 2004 Jan; 137(1):1-17. PubMed ID: 14700638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
    Bosch-Driessen LH; Verbraak FD; Suttorp-Schulten MS; van Ruyven RL; Klok AM; Hoyng CB; Rothova A
    Am J Ophthalmol; 2002 Jul; 134(1):34-40. PubMed ID: 12095805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current practice in the management of ocular toxoplasmosis.
    Yogeswaran K; Furtado JM; Bodaghi B; Matthews JM; ; Smith JR
    Br J Ophthalmol; 2023 Jul; 107(7):973-979. PubMed ID: 35197262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion.
    Holland GN
    Ophthalmology; 2005 Nov; 112(11):1882-4. PubMed ID: 16271316
    [No Abstract]   [Full Text] [Related]  

  • 15. Ocular manifestations of systemic disease: toxoplasmosis.
    Vasconcelos-Santos DV
    Curr Opin Ophthalmol; 2012 Nov; 23(6):543-50. PubMed ID: 23047172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
    Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
    Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Toxoplasmosis in Tropical Areas: Analysis and Outcome of 190 Patients from a Multicenter Collaborative Study.
    Huang PK; Jianping C; Vasconcelos-Santos DV; Arruda JSD; Dutta Majumder P; Anthony E; Ganesh SK; Biswas J; Ling HS; Teoh SC; Agrawal R
    Ocul Immunol Inflamm; 2018; 26(8):1289-1296. PubMed ID: 29020481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of toxoplasmic uveitis treated with pyrimethamine and sulpha drugs in Egypt (case report).
    Rifaat MA; Sadek MS; el-Naggar BA; Munir AM
    J Trop Med Hyg; 1973 Oct; 76(10):252-3. PubMed ID: 4752162
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ocular toxoplasmosis].
    Pleyer U; Torun N; Liesenfeld O
    Ophthalmologe; 2007 Jul; 104(7):603-15, quiz 616. PubMed ID: 17530262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of trimethoprim/ sulfamethoxazole treatment for ocular toxoplasmosis in Congolese patients.
    Nsiangani Lusambo N; Kaimbo Wa Kaimbo D; Ngoyi Mumba DM; de-la-Torre A
    BMC Ophthalmol; 2023 Oct; 23(1):440. PubMed ID: 37907920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.